Meeder Asset Management’s Acadia Healthcare ACHC Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q2
Sell
-44
Closed -$3.49K 852
2024
Q1
$3.49K Buy
+44
New +$3.6K ﹤0.01% 684
2023
Q1
Sell
-388
Closed -$31.9K 594
2022
Q4
$31.9K Sell
388
-252
-39% -$20.8K ﹤0.01% 571
2022
Q3
$50K Buy
640
+367
+134% +$29.3K ﹤0.01% 849
2022
Q2
$18K Sell
273
-3
-1% -$209 ﹤0.01% 1164
2022
Q1
$18K Buy
+276
New +$16K ﹤0.01% 1317
2021
Q4
Sell
-229
Closed -$15K 1097
2021
Q3
$15K Buy
229
+48
+27% +$3.03K ﹤0.01% 1511
2021
Q2
$11K Sell
181
-7
-4% -$439 ﹤0.01% 1648
2021
Q1
$11K Buy
188
+12
+7% +$649 ﹤0.01% 1573
2020
Q4
$9K Buy
176
+58
+49% +$2.31K ﹤0.01% 1011
2020
Q3
$3K Buy
118
+65
+123% +$1.89K ﹤0.01% 1698
2020
Q2
$1K Sell
53
-42
-44% -$1.05K ﹤0.01% 1846
2020
Q1
$2K Sell
95
-8
-8% -$229 ﹤0.01% 2049
2019
Q4
$3K Buy
103
+51
+98% +$1.6K ﹤0.01% 1903
2019
Q3
$2K Sell
52
-32
-38% -$974 ﹤0.01% 1930
2019
Q2
$3K Buy
+84
New +$2.72K ﹤0.01% 1777
2016
Q1
Sell
-124
Closed -$8K 831
2015
Q4
$8K Buy
+124
New +$8.08K ﹤0.01% 773

Other funds holding ACHC

Meeder Asset Management's ACHC Position: Q2 2024 in Review

Meeder Asset Management sold out of Acadia Healthcare (ACHC) in Q2 2024, closing a stake of 44 shares — an estimated $3.49K sold.

Meeder Asset Management first reported a position in ACHC in Q4 2015 and held it in 16 quarters. The position peaked at $50K in Q3 2022. 305 funds tracked by Wall St. Rank hold ACHC as of Q2 2024.

  • Meeder Asset Management reported no remaining Acadia Healthcare position as of Q2 2024 after selling out during the quarter.
  • Meeder Asset Management sold 44 Acadia Healthcare shares in Q2 2024, an estimated $3.49K.
  • Meeder Asset Management first reported a position in Acadia Healthcare in Q4 2015 and held it in 16 quarters.
  • Meeder Asset Management's Acadia Healthcare position peaked at $50K in Q3 2022.
  • 305 funds tracked by Wall St. Rank held Acadia Healthcare as of Q2 2024.

Based on Meeder Asset Management's 13F filing for Q2 2024, filed 8 Aug 2024.